Acadian Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Buy |
|
|||||
|
2025
Q1 | $10.2M | Buy |
|
|||||
|
2024
Q4 | $6.33M | Sell |
|
|||||
|
2024
Q3 | $6.82M | Sell |
|
|||||
|
2024
Q2 | $4.52M | Buy |
|
|||||
|
2024
Q1 | $8.09M | Buy |
|
|||||
|
2023
Q4 | $6.7M | Sell |
|
|||||
|
2023
Q3 | $5.03M | Buy |
|
|||||
|
2023
Q2 | $5.91M | Buy |
|
|||||
|
2023
Q1 | $4.91M | Buy |
|
|||||
|
2022
Q4 | $5.31M | Buy |
|
|||||
|
2022
Q3 | $2.58M | Sell |
|
|||||
|
2022
Q2 | $2.51M | Buy |
|
|||||
|
2022
Q1 | $2.43M | Buy |
|
|||||
|
2021
Q4 | $1.55M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $594K | Sell |
|
|||||
|
2020
Q3 | $2.9M | Sell |
|
|||||
|
2020
Q2 | $2.58M | Buy |
|
|||||
|
2020
Q1 | $2.05M | Buy |
|
|||||
|
2019
Q4 | $2M | Buy |
|
|||||
|
2019
Q3 | $606K | Buy |
|
|||||
|
2019
Q2 | $663K | Buy |
|
|||||
|
2019
Q1 | $101K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $486K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $351K | Buy |
|
|||||
|
2015
Q4 | $59K | Buy |
|
|||||
|
2015
Q3 | $1K | Sell |
|
|||||
|
2015
Q2 | $16K | Buy |
|
|||||
|
2015
Q1 | $15K | Buy |
|